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The Global Initiative for chronic Obstructive Lung disease (GOLD)
guideline of 2018 describes COPD as ‘the result of a complex
interplay of long-term cumulative exposure to noxious gases and
particles, combined with a variety of host factors including
genetics, airway hyper-responsiveness and poor lung growth
during childhood’.1 Tobacco smoking is traditionally viewed as the
main contributing factor to the development of COPD. However,
COPD also occurs among non-smokers, especially in low-income
and middle-income countries (LMICs).2,3 Notably, more than 90%
of COPD-related deaths occur in LMICs.4 For these countries, other
risk factors, such as ambient, occupational and household air
pollution play a signiﬁcant role in the development of COPD.1,2,5–7
Does COPD in these settings have a different pathophysiological
trajectory compared to COPD in high-income countries, and if so:
what does this imply?
In normal lung development, airway branching is completed by
the 17th week of gestation, after which airways increase in volume
until young adulthood. Alveoli are present at birth and develop
further during childhood. Lung volume and airﬂow continue to
increase as the thorax grows, inﬂuenced by age, sex, and ethnicity,
reaching a peak at young adulthood. Lung function then remains
constant for about 10 years (the plateau phase), after which it
gradually declines.8 In the ‘classic’ COPD patient, the decline in
lung function is more rapid than in healthy individuals. However,
in a considerable proportion of COPD patients, lung function does
not decline rapidly, but reaches a lower plateau phase in early
adulthood instead. For these patients, a completely different
pathophysiological trajectory seems to lead to the diagnosis of
COPD: the decline in lung function follows a normal pattern, yet
they seem to have a ‘false start’ by attaining a lower maximum
lung function.8–11
Several factors can contribute to a lower maximum lung
function. There is increasing evidence that different environmen-
tal factors (such as tobacco smoke, household air pollution caused
by burning solid fuels or kerosene lamps), maternal factors
(malnutrition, asthma, diabetes), and gene–environment interac-
tions can impact lung growth. Additionally, childhood factors (low
birth weight, prematurity) and other diseases during childhood
(lower respiratory tract infections, asthma, tuberculosis, HIV) may
all contribute to a decline in lung function.1–3,5,8,9,11–14 (Mal)
nutrition additionally plays a vital role in lung development.15
Unfortunately, many of these factors commonly interrelate and
co-occur in LMICs. A low socioeconomic status can furthermore
deteriorate the situation, as this is not only independently
associated with a lower lung function, but also with other health
risks (poor access to healthcare, poor nutrition, low birth weight,
exposure to indoor and outdoor pollution, poor living conditions
and water supply/sanitation).16–18 Overall, populations in LMICs
are particularly vulnerable to such risk factors for a lower
maximum lung function.16,18
Our knowledge about reduced maximum attained lung
functions caused by ‘early life disadvantage factors’ in LMICs
seems humble compared to the knowledge generated by
extensive research on tobacco-related COPD, often conducted in
high-income countries.5,11,13,19 The question is whether these early
life, disadvantageous factors cause different COPD phenotypes
with their own pathophysiology, diagnostic approach, rate of lung
function decline, response to treatment, and potential reversi-
bility.3,9,13,19 The paucity of data indicates differences may exist,
and that those with a lower forced expiratory volume in one
second in early adulthood are also exposed to an increased
prevalence and earlier incidence of other non-communicable
diseases and premature death.5,12,20,21 Additionally, COPD related
to biomass fuel smoke was demonstrated to be commonly
present among young, non-smoking women,6 whereas ‘classic’
COPD patients are elderly, smoking men. Such difference could be
attributed to differences in risk exposure between men and
women, yet potential differences in sensitivity to COPD between
men and women per phenotype could play an additional role.
Furthermore, as rates of lung function decline vary according to
the underlying cause of COPD, the approach equally differs. For
tobacco or biomass fuel smoke exposure the decline may
decelerate once removed from the exposure, whereas a normal
decline within patients with a lower plateau phase seems harder
to inﬂuence.
COPD caused by a false start has several implications. First,
COPD caused by early life disadvantage factors should be tackled
at much earlier stages. Prevention is key, and must start before
birth, continue throughout childhood and then be combined with
the ‘regular’ preventive measures targeting an accelerated decline.
As early life disadvantage factors are diverse, prevention addres-
sing these factors should be equally diverse. We argue that raising
awareness on COPD is therefore crucial. COPD, the third cause of
death worldwide, is often completely unknown to local commu-
nity members, including their healthcare professionals and policy
makers.22 Local curricula for healthcare professionals (doctors,
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nurses, midwives) thus need to increase focus on COPD and on its
early origin. Moreover, community health workers should be
trained on a national scale to facilitate COPD awareness
programmes in their communities. Raising awareness among
policy makers is also essential. The diverse early life risk factors
require COPD interventions to be embedded in a wide, inter-
sectoral approach to facilitate a socioeconomic upliftment
(targeting amongst others poverty, education, infrastructure,
health literacy).
Increased awareness on the early development of COPD and on
the existence of COPD in general could enhance early diagnosis
and timely action. Increased awareness is particularly important
considering the widescale underdiagnosis of COPD. This raises the
question how to best diagnose the disease (affordably, easy to
learn), and how to do so at an early stage.6,23 Although affordable
medications to treat COPD in LMICs are rare, non-pharmacological
approaches, such as pulmonary rehabilitation and patient educa-
tion can impact COPD symptoms and disease progression.
Particularly in LMICs, these approaches seem cost-effective (if
not, cost-saving).24
The second implication is related to research. As outlined
earlier, more research into a lower maximum lung function and its
clinical implications is needed. Furthermore, a false start implies a
different perspective on how to study the effect of interventions
targeting household air pollution on lung function. For decades,
clean cook stove programmes fail to demonstrate consistent
positive effects on lung function.25 Often this is attributed to
ﬂawed implementation of such interventions, or to cross-
contamination of air pollution within the community. However,
even after successful adoption of clean cook stoves, the lungs in
this generation could remain irreversibly damaged. Instead,
should we not measure effects on lung function among children
and adolescents, or even among the next (unborn) generation?
To conclude, COPD development generally starts early in life
due to a complex interplay of disadvantageous factors. Many of
these factors particularly occur in LMICs. To address the silent
growing epidemic of COPD in LMICs, lung health should be
optimised even before birth and in early childhood. Prevention is
key, and focus should be on creating large-scale awareness—
beyond the healthcare system only, involving all stakeholders.
More research is needed to explore the implications of early life
disadvantage factors for COPD in LMICs. This should lead to an
evidence-based approach for those with a false start—those (at
risk of) having a lower maximum lung function.
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